المؤلفون: Peyvandi, Flora, Cataland, Spero, Scully, Marie, Coppo, Paul, Knoebl, Paul, Kremer Hovinga, Johanna A., Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Minkue Mi Edou, Jessica, De Winter, Hilde, Callewaert, Filip

المصدر: Peyvandi, Flora; Cataland, Spero; Scully, Marie; Coppo, Paul; Knoebl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood advances, 5(8), pp. 2137-2141. American Society of Hematology 10.1182/bloodadvances.2020001834

مصطلحات موضوعية: 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://boris.unibe.ch/156090Test/

الإتاحة: https://doi.org/10.1182/bloodadvances.2020001834Test
https://boris.unibe.ch/156090/1/Caplacizumab_prevents_advancesadv2020001834.pdfTest
https://boris.unibe.ch/156090Test/

المؤلفون: Metjian, Ara D.¹

المصدر: Blood. 10/22/2015, Vol. 126 Issue 17, p1975-1976. 2p.

مصطلحات موضوعية: *VON Willebrand factor, *HEMORRHAGE treatment, *VON Willebrand disease treatment, *CLINICAL trials, *PHARMACOKINETICS